Schlagwort: ‘Coopetition’

Ningbo: medical insurance will not reimburse drugs that are not included in the “selected drugs”-list

June 17th, 2020 | by

On June 19th, the Ningbo Municipal Medical Insurance Bureau collects opinions from the whole society for the plan of centralized procurement of medicines and medical consumable materials in public medical institutions. The “Plan” stipulates that the medical insurance fund will not pay for medicines that are similar to the selected drugs but are not included in the list of selected drugs.



来源:医药网  2020.06.17


The “One Invoice Policy” will be implemented

March 9th, 2020 | by

On March 5th, the State Council issued a document on reforming the medical and health care system. The document indicates that a regional and a national allied procurement system should be implemented to realize an orderly drug supply system with reasonable prices and competition; medical insurance agencies should deal with the settlement payment directly with manufacturers or pharmaceutical companies. Besides, provincial centralized procurement platforms that are based on medical insurance payment should be established, which combines bidding, procurement, trading, settlement, and supervision.


国务院:推行一票制 经销商结款方式要变了

来源:医药网  2020.03.09


“Drug Evaluation Report in 2018” is released

July 1st, 2019 | by

On July 1st, the National Medical Products Administration(NMPA) issued the “Drug Evaluation Report in 2018.” The “Report” shows that the Drug Evaluation Centre of the NMPA reviewed and approved 106 new drugs in 2018. Although the number of applications for registration of new drugs has increased by 47%, the evaluation time has been reduced significantly in comparison to 2017. Benefiting from the accelerated drug evaluation reforms, the number of applications for registration of innovative drugs has increased significantly in 2018, of which 85% were from domestic companies. At the same time, in order to improve the quality of generic drugs, the Drug Evaluation Centre has made every effort to promote the “Quality Consistency Evaluation for Generic Drugs,” and there were eight batches of generic drugs that are involved in comparison to 2018.


来源:中国医药报 2019.07.01


“List of imported drugs that are suggested to be imitated” is released

June 21st, 2019 | by

On June 20th, the National Health Commission issued the initial “List of imported drugs that are suggested to be imitated.” The National Health Commission has cooperated with the National Medical Products Administration and other departments to organise experts to select a total of 34 drugs whose patents expire or patents that are about to expire but have not been filed for registration. The “List” also includes drugs that are in short supply or actively declared by enterprises.

首批鼓励仿制药品目录 34个药品入选

来源:医药网 2019.06.21


Difficulties with sharing prescriptions

May 4th, 2018 | by

In October 2017, all pharmacies in Wuzhou, Guangxi started to share prescriptions. By means of the prescription within 24 hours, patients can go to any pharmacy which joins the sharing platform to pay the medication fee and buy drugs. This means four months later – after the beginning of the pilot project in May – the prescription information sharing platform, which is promoted by Health and Family Planning Commission Wuzhou, officially reached the implement phase. (Source: 21st Century Pharmacy)


来源:21世纪药店 2017-10-13


Hospitals default in tens of billions – the department of commerce starts to intervene

January 31st, 2017 | by

A while ago, the department of Commerce in Hunan sent letters to the health reform office in Hunan and informed them that several hospitals in Hunan have stopped the payments for drugs for three months because “the drug operation cost and drug management fee were not embodied in hospitals”. Recently, the pharmaceutical distribution industry association Hunan showed that since the beginning of 2016, 20 public hospitals have defaulted on the drug payment in more than 10 billion yuan. To maintain the normal supply, some pharmaceutical manufacturers have to take out loans from non-government institutions with high interest rates. The loss from it can be 200 thousand yuan per month. (Source: Bioon)


来源:生物谷 2016-12-22


Pilot “electronic prescriptions” in retail pharmacies in Chengdu

November 23rd, 2016 | by

To solve the problems of the sale and supervision of prescription drugs, and to meet the demand of purchasing drugs, the pilot project of “electronic prescriptions” is being carried out in Chengdu. Until now, around 3000 pharmacies in Chengdu offer the consultation service, and 1800 pharmacies carry out the pilot project of electronic prescriptions, where people can get consultations, electronic prescriptions and review electronic prescriptions for free. (Source: Economic Information Daily)


来源:经济参考报 2016-11-11


2016 Chinese cross-border medicine trade development summit meeting wrapped up

November 23rd, 2016 | by

The 2016 Chinese cross-border medicine trade development summit meeting, i.e. the special discussion forum of the Indian market, was held on 24th -25th October in Shenzhen. This summit meeting was organized by Drugdu and China Healthcare Business Development (CHBD) and attracted more than 100 people to discuss the future development of the medicine cross-border industry together. Participants included leaders of excellent Chinese and Indian pharmaceutical enterprises, pharmaceutical researchers, Internet pioneers of vertical industry and financial investments elites. The discussion of the summit meeting focused on: (1) the basic rule and cooperation model of overseas market development; (2) registration regulation requirements and the characters of market channels in developing countries; (3) integration of platform sources and transboundary development. (Source: Bioon)


来源:生物谷 2016-10-26


Ali Health bought a pharmacy with an online trading license for 16.8 million

August 4th, 2016 | by

On 6th July, Ali Health signed an acquisition agreement with the “five-thousand-year pharmacy”. Ali Health buys all the equity from the “five-thousand-year pharmacy” for 16.8 million. The “Five-thousand-year pharmacy” mainly works on the business of the retail of medicine and Chinese herbal medicine, and runs the pharmaceutical retail chain stores. It has an Internet drug transaction services qualification certificate and is allowed to sell OTC and other drugs online according to relative policies. (Source: Netease)


来源:网易 2016-07-07


[hide for= “!logged”]





Shunfeng paticipates the distribution of second vaccination

July 12th, 2016 | by

For a long time, the distribution of second vaccination in China has been complex and complicated, so that the supply and service capacity of the industry is relatively bad. After the new policy about second vaccination in April 2016, the wholesale enterprises are out. The business of the logistics distribution is newly divided. On 28th June, the person in charge of cold transportation at Shunfeng said that the cold transportation at Shunfeng has already taken part in the distribution business of second vaccination. Shunfeng starts to deploy the cold-chain transportation capacity according to the situation of the whole industry. (Source: Caixin)

顺丰参与二类疫苗配送 规划布局冷链运输

来源:财新网 2016-07-05


[hide for= “!logged”]



医药冷链物流垄断现象显着。马建聪介绍说,冷链物流一般由药品商业流通主导,销售分销决定了冷链药品的流向,各个商业企业均根据自身的销售情况建立自 己冷链配送模式。相较而言,社会物流企业专业化程度低,缺乏冷链药品的配送经验和专业知识,如果没有进行专业的培训,在提供运输服务时容易发生运输风险, 从而导致药品企业不信任社会物流企业的冷链物流能力。另外,多级分销制导致冷链药品流通的环节多,各环节冷链物流能力参差不齐,运输过程质量难以管控。

4月25日,山东疫苗案之后,国务院颁布新政《国务院关于修改〈疫苗流通和预防接种管理条例〉的决定》(下称《决定》。新政规定,二类疫苗采购纳入省 级集中招标平台,二类疫苗批发企业全部出局,二类疫苗生产企业负责对接并配送到县级疾控机构,县级疾控机构再向下供应到各基层接种点。

医药冷链配送的难点在于经历多个物流环节,不同的环节使用不同的运输资源和信息系统,要实现药品流通全程的信息共享和全程温控,势必需要有统一的标准 和执行标准的能力。业内普遍认为,新政凸显了国家规范药品行业的决心,中国的医药冷链行业将在2016年进入高速发展的快车道。


在二类疫苗配送领域,疫苗生产商自建队伍、疾控系统自营冷链系统、疫苗批发企业转型、传统医药流通龙头及传统物流巨头将重新划分蛋糕。马建聪认为,冷 链药品物流未来的市场格局将分由两个部分做主力支撑:传统医药流通的巨头企业、社会物流企业中医药冷运的专业公司。“后者正在崛起中,物流服务的基因带给 这些企业以市场化和资源配置的不同角度,存在令药品流通行业的服务更加优质的竞争机会。”

但也有分析认为,顺丰等物流龙头企业花大价钱博取小市场并不划算,深度介入疫苗流通领域的可能性不大。安信证券研报认为,目前可能会接手疫苗配送业务 的有两种:国药等医药流通龙头冷链配送能力强,资源丰富,参与二类疫苗流通的概率较大;而疫苗厂商完全自营配送队伍的成本较高,有望与转型配送服务的原疫 苗批发企业再次携手合作。

顺丰则认为,作为具备丰富物流经验和运输管理能力的公司,顺丰拥有的网络覆盖资源不容小觑。“顺丰正在针对整个行业的分布情况,配置冷链运输能力,特 别是冷藏专用车辆。用于医药运输的专用冷藏车也分为干线运输车辆和支线运输车辆两种,其中干线车辆主要用于承接疫苗生产企业的整车运输业务,支线车辆主要 用于承接同省配送至区县疾控中心业务。从目前顺丰的业务布局看,支线车辆主要集中在四川、江苏、东北、广东等几个省份。”马建聪表示,顺丰作为民营企业在 投资管理模式和企业决策执行上具备更多活力,顺丰正在加大医药专用投资和人才配置,并发挥第三方平台的开放优势,在规范市场中获得发展机会。